BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 6342901)

  • 1. Pharmacokinetic drug interactions with propranolol.
    Wood AJ; Feely J
    Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic drug interactions with theophylline.
    Jonkman JH; Upton RA
    Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetic basis for H2-antagonist drug interactions: concepts and implications.
    Powell JR; Donn KH
    J Clin Gastroenterol; 1983; 5 Suppl 1():95-113. PubMed ID: 6140286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine drug-drug interactions commonly occurring in clinical practice.
    Abernethy DR; Greenblatt DJ; Ochs HR; Shader RI
    Curr Med Res Opin; 1984; 8 Suppl 4():80-93. PubMed ID: 6144465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of propranolol metabolism by rifampicin.
    Herman RJ; Nakamura K; Wilkinson GR; Wood AJ
    Br J Clin Pharmacol; 1983 Nov; 16(5):565-9. PubMed ID: 6639842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cimetidine and ranitidine on cardiovascular drugs.
    Baciewicz AM; Baciewicz FA
    Am Heart J; 1989 Jul; 118(1):144-54. PubMed ID: 2662728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of liver blood flow and propranolol metabolism by cimetidine.
    Feely J; Wilkinson GR; Wood AJ
    N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of histamine H2-receptor antagonists on the hepatic elimination of drugs].
    Klotz U; Reimann I
    Klin Wochenschr; 1983 Jul; 61(13):625-32. PubMed ID: 6136626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug kinetics and alcohol ingestion.
    Sellers EM; Holloway MR
    Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic drug interactions in anaesthetic practice.
    Wood M
    Clin Pharmacokinet; 1991 Oct; 21(4):285-307. PubMed ID: 1760901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole drug interaction studies.
    Andersson T
    Clin Pharmacokinet; 1991 Sep; 21(3):195-212. PubMed ID: 1764870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.
    Bai SA; Abramson FP
    J Pharmacokinet Biopharm; 1984 Jun; 12(3):333-49. PubMed ID: 6502474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme induction and beta-adrenergic receptor blocking drugs.
    Branch RA; Herman RJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):77S-84S. PubMed ID: 6146342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cimetidine with other drugs.
    Feely J
    South Med J; 1983 Jun; 76(6):753-8. PubMed ID: 6344228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effects of cimetidine on elimination and distribution of propranolol in rats.
    Shibasaki S; Asahina M; Kawamata Y; Kojo M; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Sep; 12(9):549-57. PubMed ID: 2614643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol disposition in chronic liver disease: a physiological approach.
    Branch RA; Shand DG
    Clin Pharmacokinet; 1976; 1(4):264-79. PubMed ID: 797499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
    Sawada Y; Hanano M; Sugiyama Y; Iga T
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.